Nicole Basset-Seguin - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Nicole Basset-Seguin

This paper is made freely available by the publisher.

2022 Parna Moghadam

ORCID

, Florian Herms

ORCID

, Barouyr Baroudjian

ORCID

, Pauline Tetu, Julie Delyon, Fanélie Jouenne, Marie Boisson, Baptiste Louveau, Samia Mourah, Florence Brunet‐Possenti

ORCID

, Lucie Duverger, Valérie Gounant, Céleste Lebbé, Nicole Basset‐Seguin

ORCID

Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

2020 R. Dummer

ORCID

, P. A. Ascierto, N. Basset‐Seguin

ORCID

ORCID

, C. Garbe

ORCID

, R. Gutzmer, A. Hauschild, R. Krattinger, J. T. Lear, J. Malvehy, D. Schadendorf, R. J. J. Grob

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion

Upload

This paper is made freely available by the publisher.

John T. Lear, Axel Hauschild

ORCID

, Eggert Stockfleth, Nicholas Squittieri, Nicole Basset-Seguin

ORCID

, Reinhard Dummer

ORCID

<p>Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial</p>

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2019 M. Ighilahriz, M. Benfodda, H. Sharpe

ORCID

, N. Soufir, S. Mourah, N. Dumaz, M. Battistella, A. Savina, F. Bouquet, S. Nikolaev, N. Basset‐Seguin

ORCID

Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation

Upload

Missing publications? Search for publications with a matching author name.